文献速递外周动脉疾病

平均风险与高风险慢性肢体威胁性缺血患者的腹股沟下旁路手术与血管内血运重建比较

Infra-inguinal bypass surgery vs endovascular revascularization for chronic limb-threatening ischemia in average- and high-risk patients.
PubMed 文献 · J Vasc Surg · 2024-03-24

本研究回顾性分析多中心2015至2022年因慢性肢体威胁性缺血(CLTI)行腹股沟下血运重建的患者数据,按SPINACH计算器分为平均风险和高风险,倾向性评分匹配后比较旁路手术与血管内治疗(EVT)的结局。平均风险患者中,旁路手术的2年无截肢生存(AFS)、肢体挽救(LS)和伤口愈合均优于EVT;高风险患者中两组无显著差异。

要点

  • 平均风险患者中,旁路手术的2年AFS和LS优于EVT。
  • 平均风险患者中,旁路手术的1年伤口愈合率优于EVT。
  • 高风险患者中,旁路手术与EVT的2年AFS、LS和伤口愈合无显著差异。

核心结论

  • 在平均风险患者中,旁路手术在AFS、LS和伤口愈合方面优于EVT;在高风险患者中,基于2年AFS率无显著差异,EVT是可行的首选治疗策略。

研究设计与样本

  • 回顾性分析2015至2022年多中心因CLTI行腹股沟下血运重建的患者数据。
  • 高风险患者定义为SPINACH计算器估算的30天死亡率≥5%或2年生存率≤50%。
  • 采用倾向性评分匹配分别比较平均风险和高风险患者中旁路手术与EVT的结局。

主要发现

  • 平均风险患者中,匹配239对;旁路组与EVT组的2年AFS率分别为78.1%和63.0%(P < .001),2年LS率分别为94.4%和87.7%(P = .007)。
  • 平均风险患者中,旁路组与EVT组的1年伤口愈合率分别为88.6%和76.8%(P < .001)。
  • 平均风险患者中,旁路组与EVT组的30天死亡率均为0.8%(P = .996)。
  • 高风险患者中,匹配31对;旁路组与EVT组的AFS、LS和伤口愈合无显著差异(P = .591、P = .148和P = .074)。
  • 高风险患者中,旁路组与EVT组的30天死亡率均为3.2%(P = .991)。

临床怎么用

  • 作者认为,在平均风险患者中,旁路手术在AFS、LS和伤口愈合方面优于EVT。
  • 作者认为,基于2年AFS率无显著差异,EVT是高风险CLTI患者血运重建的可行首选治疗策略。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to evaluate treatment outcomes after bypass surgery or endovascular therapy (EVT) in average- and high-risk patients with chronic limb-threatening ischemia (CLTI). METHODS: We retrospectively analyzed multicenter data of patients who underwent infra-inguinal revascularization for CLTI between 2015 and 2022. A high-risk patient was defined as one with estimated 30-day mortality rate ≥5% or 2-year survival rate ≤50%, as determined by the Surgical Reconstruction vs Peripheral Intervention in Patients With Critical Limb Ischemia (SPINACH) calculator. The amputation-free survival (AFS), limb salvage (LS), wound healing, and 30-day mortality were compared separately for the average- and high-risk patients between the bypass and EVT with propensity score matching. RESULTS: We analyzed 239 and 31 propensity score-matched pairs in the average- and high-risk patients with CLTI. In the average-risk patients, the 2-year AFS and LS rates were 78.1% and 94.4% in the bypass group and 63.0% and 87.7% in the EVT group (P < .001 and P = .007), respectively. The 1-year wound healing rates were 88.6% in the bypass group and 76.8% in the EVT group, respectively (P < .001). The 30-day mortality was 0.8% in the bypass surgery and 0.8% in the EVT group (P = .996). In the high-risk patients, there was no differences in the AFS, LS, and wound healing between the groups (P = .591, P = .148, and P = .074). The 30-day mortality was 3.2% in the bypass group and 3.2% in the EVT group (P = .991). CONCLUSIONS: Bypass surgery is superior to EVT with respect to the AFS, LS, and wound healing in the average-risk patients. EVT is a feasible first-line treatment strategy for high-risk patients with CLTI undergoing revascularization, based on the lack of significant differences in the 2-year AFS rate, between the bypass surgery and EVT cohorts.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Morisaki K, Matsuda D, Guntani A, et al. Infra-inguinal bypass surgery vs endovascular revascularization for chronic limb-threatening ischemia in average- and high-risk patients. J Vasc Surg. 2024. PMID: 38522583. doi:10.1016/j.jvs.2024.03.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。